インタープロテイン株式会社

Interprotein provides highly active modulators for protein-protein interaction (PPI) targets.

Based based in Tokyo, Japan, インタープロテイン株式会社 works in deeptech, founded in 2001.

Profile

Interprotein is a pioneering deeptech company specializing in providing highly active modulators for protein-protein interaction (PPI) targets. With twin platform technologies, Interprotein offers unique compounds with high activity and low nanomolar KD values, revolutionizing drug discovery in the field of PPI modulation. Their proprietary technology, INTENDD®, and helix-loop-helix peptide libraries enable the identification of strong binders for therapeutic intervention. By analyzing and exploiting PPI interfaces, Interprotein aims to develop small molecule and peptide PPI modulators, addressing the growing need for innovative drug discovery solutions. Their commitment to collaborative R&D efforts and the development of AI-based drug discovery programs showcases their dedication to transforming biologics-based PPI inhibitions into patient-friendly therapies, ultimately changing lives in the healthcare industry.

インタープロテイン株式会社 is positioned in deeptech, a segment that rewards a clear, focused offering.

The company is recorded as being based in Tokyo, Japan.

It is recorded at the Plug and Play portfolio startup stage.

The company reports a headcount in the c_00011_00050 range.

Website: www.interprotein.com